» Articles » PMID: 34965215

LINC00839 Knockdown Restrains the Metastatic Behavior of Nasopharyngeal Carcinoma by Sponging MiR-454-3p

Overview
Specialty Geriatrics
Date 2021 Dec 29
PMID 34965215
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Long intergenic non-coding RNA 00839 (LINC00839) has been verified as a pro-metastasis factor in malignancies. However, the significance of LINC00839 in nasopharyngeal carcinoma (NPC) has yet to be illuminated, as well as its underlying mechanism. Here, we disclosed that LINC00839 is highly expressed in NPC. Deletion of LINC00839 suppresses NPC cells rapid growth, invasive capacity and EMT . Besides, LINC00839 is identified as a "sponge" for miR-454-3p, and upregulation of LINC00839 reverses miR-454-3p-mediated inhibition of aggressiveness in NPC cells. Furthermore, the expression of cellular-mesenchymal epithelial transition factor (c-Met), the downstream target of miR-454-3p, is downregulated by LINC00839 knockdown in NPC cells. , LINC00839 knockdown retards the tumor growth of NPC cells in the xenografted mice model. Collectively, attenuation of LINC00839 expression attenuates the aggressive properties of NPC cells via directly sponging the miR-454-3p and regulating c-Met expression.

Citing Articles

The role of long non-coding RNA LINC00839 in oral squamous cell carcinoma based on bioinformatics and experimental research.

Kalantary-Charvadeh A, Morovat S, Aslani S, Ziamajidi N, Emami Razavi A, Abbasalipourkabir R Sci Rep. 2024; 14(1):31817.

PMID: 39738469 PMC: 11686358. DOI: 10.1038/s41598-024-82922-6.


MiR-454-3p regulates high glucose-induced mesothelial-mesenchymal transition and glycolysis in peritoneal mesothelial cells by targeting STAT3.

Li N, Fu J, Wang Q, Rao Q, Yao L, Shao X Ren Fail. 2024; 46(2):2394635.

PMID: 39192609 PMC: 11360635. DOI: 10.1080/0886022X.2024.2394635.


LINC00839 in Human Disorders: Insights into its Regulatory Roles and Clinical Impact, with a Special Focus on Cancer.

Hu Y, Hu Y, Lu X, Luo H, Chen Z J Cancer. 2024; 15(8):2179-2192.

PMID: 38495499 PMC: 10937278. DOI: 10.7150/jca.93820.


LINC00839 promotes malignancy of liver cancer via binding FMNL2 under hypoxia.

Xie Y, Lin H, Wei W, Kong Y, Fang Q, Chen E Sci Rep. 2022; 12(1):18757.

PMID: 36335129 PMC: 9637198. DOI: 10.1038/s41598-022-16972-z.

References
1.
Meng X, Fang E, Zhao X, Feng J . Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma. Cancer Med. 2020; 9(11):3800-3815. PMC: 7286466. DOI: 10.1002/cam4.3022. View

2.
Wen X, Liu X, Mao Y, Yang X, Wang Y, Zhang P . Long non-coding RNA DANCR stabilizes HIF-1α and promotes metastasis by interacting with NF90/NF45 complex in nasopharyngeal carcinoma. Theranostics. 2018; 8(20):5676-5689. PMC: 6276287. DOI: 10.7150/thno.28538. View

3.
Zuo J, Yu H, Xie P, Liu W, Wang K, Ni H . miR-454-3p exerts tumor-suppressive functions by down-regulation of NFATc2 in glioblastoma. Gene. 2019; 710:233-239. DOI: 10.1016/j.gene.2019.06.008. View

4.
Horikawa T, Sheen T, Takeshita H, Sato H, Furukawa M, Yoshizaki T . Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. Am J Pathol. 2001; 159(1):27-33. PMC: 1850422. DOI: 10.1016/S0002-9440(10)61669-0. View

5.
Huang L, Xie K, Li H, Wang R, Xu X, Chen K . Suppression of c-Met-Overexpressing Tumors by a Novel c-Met/CD3 Bispecific Antibody. Drug Des Devel Ther. 2020; 14:3201-3214. PMC: 7495354. DOI: 10.2147/DDDT.S254117. View